Skip navigation

Edwards Lifesciences Corp.

NYS : EW
Pharmaceuticals
Irvine CA
2013 Revenue (US$ Millions)$2,046
2012 Revenue (US$ Millions)$1,900
Revenue Growth (%)7.68%
Net Income (US$ Millions)$392
Common Shares Outstanding (Millions)$109
Earnings Per Share (US$)$3.44
Price To Earnings Ratio94.56
Total Equity (US$ Millions)$1,559
Profit Margin (%)19.15%
Return On Equity (%)26.48%
Long Term Debt (US$ Millions)$593
Debt To Equity Ratio (%)0.38%
Market Capitalization (US$ Millions)$7,188
Total Assets (US$ Millions)$2,725
Return on Assets (%)17.63
Current Assets (US$ Millions)$1,726
Inventories (US$ Millions)$309
Current Liabilities (US$ Millions)$346
Cost of Goods Sold (US$ Millions)$522
Asset Turnover0.75
Inventory Turnover1.77
ExchangeNYS